Impact of patient's financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes
{{output}}
Background: In Japan, medical expenses for COVID-19 treatment transitioned from full public funding support to out-of-pocket (OOP) payment by patients plus partial public support in October 2023, and public support fully ended in... ...
